EMA/PE/0000233807 - paediatric investigation plan

visugromab

Key facts

• Active substance:
  visugromab
• Therapeutic area:
  Neoplasms benign, malignant and unspecified (incl cysts and polyps)
• Decision number:
  EMA/PE/0000233807
• PIP number:
  EMA/PE/0000233807
• Pharmaceutical form(s):
  All pharmaceutical forms
• Condition(s) / indication(s):
  Treatment of non-small cell lung cancer
• Route(s) of administration:
  All routes of administration
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  19/03/2026
• Compliance check done:
  Ei

Decision

EMA/PE/0000233807: EMA decision of 19 March 2025 on the granting of a product specific waiver for visugromab

Adopted Reference Number: EMADOC-1700519818-1973487